| Title |
Ivermectin treatment in humans for reducing malaria transmission
|
|---|---|
| Published in |
Cochrane database of systematic reviews, June 2021
|
| DOI | 10.1002/14651858.cd013117.pub2 |
| Pubmed ID | |
| Authors |
Dziedzom K de Souza, Rebecca Thomas, John Bradley, Clemence Leyrat, Daniel A Boakye, Joseph Okebe |
X Demographics
The data shown below were collected from the profiles of 159 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 29 | 18% |
| United Kingdom | 10 | 6% |
| Australia | 4 | 3% |
| Canada | 4 | 3% |
| Ghana | 2 | 1% |
| Greece | 1 | <1% |
| Central African Republic | 1 | <1% |
| Antarctica | 1 | <1% |
| Israel | 1 | <1% |
| Other | 3 | 2% |
| Unknown | 103 | 65% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 143 | 90% |
| Scientists | 10 | 6% |
| Practitioners (doctors, other healthcare professionals) | 3 | 2% |
| Science communicators (journalists, bloggers, editors) | 3 | 2% |
Mendeley readers
The data shown below were compiled from readership statistics for 87 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 87 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 10 | 11% |
| Student > Master | 9 | 10% |
| Other | 6 | 7% |
| Student > Postgraduate | 6 | 7% |
| Researcher | 5 | 6% |
| Other | 13 | 15% |
| Unknown | 38 | 44% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 14 | 16% |
| Nursing and Health Professions | 8 | 9% |
| Biochemistry, Genetics and Molecular Biology | 3 | 3% |
| Agricultural and Biological Sciences | 3 | 3% |
| Pharmacology, Toxicology and Pharmaceutical Science | 3 | 3% |
| Other | 13 | 15% |
| Unknown | 43 | 49% |
Attention Score in Context
This research output has an Altmetric Attention Score of 180. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 13 November 2023.
All research outputs
#215,287
of 24,871,735 outputs
Outputs from Cochrane database of systematic reviews
#366
of 12,993 outputs
Outputs of similar age
#5,892
of 434,154 outputs
Outputs of similar age from Cochrane database of systematic reviews
#10
of 162 outputs
Altmetric has tracked 24,871,735 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 12,993 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 35.0. This one has done particularly well, scoring higher than 97% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 434,154 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 98% of its contemporaries.
We're also able to compare this research output to 162 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 94% of its contemporaries.